Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen E. Epstein is active.

Publication


Featured researches published by Stephen E. Epstein.


Circulation | 1992

Dose-dependent smooth muscle cell proliferation induced by thermal injury with pulsed infrared lasers.

Philippe Douek; Rosaly Correa; R Neville; Ellis F. Unger; M Shou; Shmuel Banai; V J Ferrans; Stephen E. Epstein; Martin B. Leon; Robert F. Bonner

Pulsed infrared laser irradiation induced localized thermal lesions in arteries by transiently heating to ∼30°C above ambient and subsequent SMC proliferation in rabbits by 3–4 weeks. Neointimal proliferation exhibited a clear dose dependence both as laser fluence was increased (R=0.83) and for a fixed surface irradiation as the depth of the nearest arterial media was decreased (R=0.9S). Thermal injury to the arterial wall is shown to be potent stimulus for SMC proliferation, favoring reduction in energies used in laser or thermal angioplasty.


Archive | 1982

Plasma Verapamil Levels in Patients with Hypertrophic Cardiomyopathy: Interpatient Variability and Clinical Usefulness

Martin B. Leon; Douglas R. Rosing; Stephen E. Epstein

Plasma verapamil levels were measured under various clinical conditions using a high-pressure liquid chromatography assay to determine their importance in guiding therapy in patients with hypertrophic cardiomyopathy. In 80 patients on chronic oral verapamil therapy, there was marked variability between patients in plasma verapamil levels for each dosage. In contrast, variability in peak and trough plasma verapamil levels for a given patientnwas relatively small (verapamil peak/trough ratio for 23 patients = 1.66 ±0.07). Plasma verapamil levels in 27 clinical responders, with improvement in NYHA functional class and >15% increase in exercise capacity, were not different from 15 nonresponders (responders = 153 ± 11, vs nonresponders = 175 ± 18 ng/ml (NS)). In 24 patients with serious electrophysiologic or hemodynamic side effects from verapamil, plasma verapamil levels ranged from 30 to 540 ng/ml (mean plasma verapamil level = 201 ± 23 ng/ml) and there was significant overlap in plasma verapamil levels compared with responders and nonresponders. Thus, in patients with hypertrophic cardiomyopathy on verapamil therapy (1) there is marked interpatient variability in plasma verapamil levels, which may be due to differences in first-pass hepatic metabolism and (2) there is considerable overlap of plasma verapamil levels in responders, nonresponders, and patients with serious side effects. Plasma verapamil levels therefore may be of limited usefulness in predicting therapeutic or toxic effects from oral verapamil therapy in patients with hypertrophic cardiomyopathy.


international conference of the ieee engineering in medicine and biology society | 1992

Dose-dependent smooth muscle cell proliferation induced by thermal injury with pulsed infrared lasers

Philippe Douek; Rosaly Correa; Ellis F. Unger; Richard Neville; Shmuel Banai; Stephen E. Epstein; Martin B. Leon; Robert F. Bonner

Pulsed infrared laser irradiation induced localized thermal lesions in arteries by transiently heating to ∼30°C above ambient and subsequent SMC proliferation in rabbits by 3–4 weeks. Neointimal proliferation exhibited a clear dose dependence both as laser fluence was increased (R=0.83) and for a fixed surface irradiation as the depth of the nearest arterial media was decreased (R=0.9S). Thermal injury to the arterial wall is shown to be potent stimulus for SMC proliferation, favoring reduction in energies used in laser or thermal angioplasty.


Archive | 1994

Inhibition of cell proliferation using antisense oligonucleotides

Stephen E. Epstein; Edith Speir; Ellis F. Unger


Archive | 2001

Methods for controlled depth injections into interior body cavities

Stephen E. Epstein; Shmuel Fuchs; Ran Kornowski


Archive | 1991

Method to foster myocardial blood vessel growth and improve blood flow to the heart

Ellis F. Unger; Stephen E. Epstein


Archive | 2001

Methods for sterile aspiration/reinjection of bodily fluid

Stephen E. Epstein; Shmuel Fuchs; Ran Kornowski


Archive | 2000

Intramyocardial injection of autologous bone marrow

Ran Komowski; Shmuel Fuchs; Stephen E. Epstein; Martin B. Leon


Archive | 2003

Inhibition of restenosis using a dna-coated stent

Stephen E. Epstein; Shmuel Fuchs


Archive | 2004

Injection of bone marrow-derived cells and medium for angiogenesis

Stephen E. Epstein; Shmuel Fuchs; Ran Kornowski; Martin B. Leon; Kenneth W. Carpenter

Collaboration


Dive into the Stephen E. Epstein's collaboration.

Top Co-Authors

Avatar

Shmuel Fuchs

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

Martin B. Leon

Columbia University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ellis F. Unger

National Center for Research Resources

View shared research outputs
Top Co-Authors

Avatar

Eugenio Stabile

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

Shmuel Banai

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Douglas R. Rosing

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Edith Speir

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Robert F. Bonner

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Rosaly Correa

National Center for Research Resources

View shared research outputs
Researchain Logo
Decentralizing Knowledge